Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1979 Sep;8(3):205–207. doi: 10.1111/j.1365-2125.1979.tb01003.x

Dosage and the pharmacokinetics of cytotoxic drugs.

J R Trounce
PMCID: PMC1429797  PMID: 497086

Full text

PDF
205

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bischoff K. B., Dedrick R. L., Zaharko D. S., Longstreth J. A. Methotrexate pharmacokinetics. J Pharm Sci. 1971 Aug;60(8):1128–1133. doi: 10.1002/jps.2600600803. [DOI] [PubMed] [Google Scholar]
  2. Bleyer A. W. Clinical pharmacology of intrathecal methotrexate. II. An improved dosage regimen derived from age-related pharmacokinetics. Cancer Treat Rep. 1977 Nov;61(8):1419–1425. [PubMed] [Google Scholar]
  3. Bleyer W. A., Dedrick R. L. Clinical pharmacology of intrathecal methotrexate. I. Pharmacokinetics in nontoxic patients after lumbar injection. Cancer Treat Rep. 1977 Jul;61(4):703–708. [PubMed] [Google Scholar]
  4. Bleyer W. A. Methotrexate: clinical pharmacology, current status and therapeutic guidelines. Cancer Treat Rev. 1977 Jun;4(2):87–101. doi: 10.1016/s0305-7372(77)80007-8. [DOI] [PubMed] [Google Scholar]
  5. Cadman E. C., Lundberg W. B., Bertino J. R. Systemic methotrexate toxicity. A pharmacological study of its occurrence after intrathecal administration in a patient with renal failure. Arch Intern Med. 1976 Nov;136(11):1321–1322. doi: 10.1001/archinte.136.11.1321. [DOI] [PubMed] [Google Scholar]
  6. Chabner B. A., Myers C. E., Oliverio V. T. Clinical pharmacology of anticancer drugs. Semin Oncol. 1977 Jun;4(2):165–191. [PubMed] [Google Scholar]
  7. Dedrick R. L., Myers C. E., Bungay P. M., DeVita V. T., Jr Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat Rep. 1978 Jan;62(1):1–11. [PubMed] [Google Scholar]
  8. Frei E., 3rd, Freireich E. J. Progress and perspectives in the chemotherapy of acute leukemia. Adv Chemother. 1965;2:269–298. doi: 10.1016/b978-1-4831-9930-6.50011-3. [DOI] [PubMed] [Google Scholar]
  9. Harris A. L., Potter C., Bunch C., Boutagy J., Harvey D. J., Grahame-Smith D. G. Pharmacokinetics of cytosine arabinoside in patients with acute myeloid leukaemia. Br J Clin Pharmacol. 1979 Sep;8(3):219–227. doi: 10.1111/j.1365-2125.1979.tb01005.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ho D. H., Brown N. S., Benvenuto J., McCredie K. B., Buckels D., Freireich E. J. Pharmacologic studies of continuous infusion of arabinosylcytosine by liquid infusion system. Clin Pharmacol Ther. 1977 Sep;22(3):371–374. doi: 10.1002/cpt1977223371. [DOI] [PubMed] [Google Scholar]
  11. Isacoff W. H., Morrison P. F., Aroesty J., Willis K. L., Block J. B., Lincoln T. L. Pharmacokinetics of high-dose methotrexate with citrovorum factor rescue. Cancer Treat Rep. 1977 Dec;61(9):1665–1674. [PubMed] [Google Scholar]
  12. Juma F. D., Rogers H. J., Trounce J. R. Pharmacokinetics of cyclophosphamide and alkylating activity in man after intravenous and oral administration. Br J Clin Pharmacol. 1979 Sep;8(3):209–217. doi: 10.1111/j.1365-2125.1979.tb01004.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Jusko W. J. Pharmacodynamics of chemotherapeutic effects: dose-time-response relationships for phase-nonspecific agents. J Pharm Sci. 1971 Jun;60(6):892–895. doi: 10.1002/jps.2600600618. [DOI] [PubMed] [Google Scholar]
  14. Mellett L. B. Physicochemical considerations and pharmacokinetic behavior in delivery of drugs to the central nervous system. Cancer Treat Rep. 1977 Jul;61(4):527–531. [PubMed] [Google Scholar]
  15. Nichol C. A. Pharmacokinetics: selectivity of action related to physicochemical properties and kinetic patterns of anticancer drugs. Cancer. 1977 Jul;40(1 Suppl):519–528. doi: 10.1002/1097-0142(197707)40:1+<519::aid-cncr2820400718>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  16. Sadee W., Wong C. G. Pharmacokinetics of 5-fluorouracil: inter-relationship with biochemical kinetics in monitoring therapy. Clin Pharmacokinet. 1977 Nov-Dec;2(6):437–450. doi: 10.2165/00003088-197702060-00004. [DOI] [PubMed] [Google Scholar]
  17. Tubiana M., Malaise E. Comparison of cell proliferation kinetics in human and experimental tumors: response to irradiation. Cancer Treat Rep. 1976 Dec;60(12):1887–1895. [PubMed] [Google Scholar]
  18. Warren R. D., Bender R. A. Drug interactions with antineoplastic agents. Cancer Treat Rep. 1977 Oct;61(7):1231–1241. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES